Long-term monitoring: We see patients at 1, 3, 6, and 12 months post-GLP-1
Sudden drops in leptin from rapid fat loss are described as potentially affecting mood, energy, and motivation in susceptible people over roughly two to six weeks
Clinical trials have demonstrated varying degrees of weight loss depending on the specific agent and dosage: semaglutide 2.4mg (Wegovy) produces approximately 15% weight loss at 68 weeks, liraglutide 3mg (Saxenda) typically achieves 5-8% weight loss, while tirzepatide has shown up to 20% weight reduction in obesity trials
This sleep test assesses the hormones which influence your sleep patterns
Our expertly crafted programs are tailored to meet your personal needs
Do not draw from the new vial until you have recalculated your units using the formula